HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C: a prospective cohort study.

AbstractAIM:
to report the prevalence, risk factors, management and long-term outcome of thyroid disorders caused by INFalpha in patients with chronic hepatitis C.
PATIENTS AND METHODS:
From January 1991 to December 2004, 625 patients with chronic hepatitis C underwent INFalpha therapy. TSH assay was normal and antithyroperoxidase antibodies (anti-TPO) was performed before onset antiviral treatment; then TSH was performed every 2 months in all patients during therapy, and every 3 months after treatment.
RESULTS:
58 patients developed thyroid disorder (8.9%). Mean age was 50.6+/-13 years; sex ratio: 1 M/2 F; the anti-TPO antibodies were positive before onset antiviral treatment in 9 patients (13.8%). 26 patients developed hypothyroidism (44.8%), 9 patients developed hyperthyroidism (15.5%) and among them 3 cases of Grave's disease. Biphasic thyroiditis occurred in 21 patients (36.2%), anti-TPO increase during treatment in 2 patients (3.5%) without hypothyroidism. The dysthyroidism was more frequent in risk in female gender (p<0.05) and in the group with positive antiTPO antibodies before treatment (p<0.02).
CONCLUSION:
Female gender and positive antiTPO antibodies are the predictive factors of development of the thyroid dysfunction during INFalpha therapy.
AuthorsN Kabbaj, M M Guedira, H El Atmani, M El Alaoui, M Mohammadi, K Benabed, H Lachkar, A Benaïssa
JournalAnnales d'endocrinologie (Ann Endocrinol (Paris)) Vol. 67 Issue 4 Pg. 343-7 (Sep 2006) ISSN: 0003-4266 [Print] France
PMID17072240 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Autoantibodies
  • Interferon-alpha
  • Thyrotropin
Topics
  • Antiviral Agents (adverse effects, therapeutic use)
  • Autoantibodies (blood)
  • Cohort Studies
  • Female
  • Genotype
  • Hepacivirus (genetics)
  • Hepatitis C, Chronic (drug therapy)
  • Humans
  • Interferon-alpha (adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Thyroid Diseases (chemically induced)
  • Thyroid Gland (immunology)
  • Thyrotropin (blood)
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: